LexDanaLexDanabeta
Inventor

LESLIE B. GORDON

Inventor
US

Overview

2→
Patents
2023–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes40%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07KPeptides20%
C12NMicroorganisms or enzymes20%
PatentTitleYear
11,857,541Combination therapies for treatment of laminopathies, cellular aging, and atherosclerosis202411,802,283Oligonucleotide analogues targeting human LMNA2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023Patents assigned to SAREPTA THERAPEUTICS INC (1)· patent assignee history
2023Patents assigned to THE PROGERIA RES FOUNDATION (1)· patent assignee history
2023–2024Based in US· patent location history
2024Patents assigned to GORDON LESLIE B (1)· patent assignee history
2024Patents assigned to KIERAN MARK W (1)· patent assignee history
2024Patents assigned to KLEINMAN MONICA E (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GORDON LESLIE Bself12024
KIERAN MARK W12024
KLEINMAN MONICA E12024
SAREPTA THERAPEUTICS INC12023
THE PROGERIA RES FOUNDATION12023
Locations
LocationPatentsSpan
US22023–2024